Immunopathogenic mechanisms of systemic autoimmune disease (Q38133018)

29 August 2017

Immunopathogenic mechanisms of systemic autoimmune disease (English)

1 reference

29 August 2017

1 reference

Marie Wahren-Herlenius

series ordinal

1

object named as

Marie Wahren-Herlenius

1 reference

29 August 2017

Thomas Dörner

2

1 reference

PubMed ID

23993191

29 August 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

29 August 2017

1 reference

29 August 2017

382

1 reference

29 August 2017

9894

1 reference

29 August 2017

819-831

1 reference

Detecting shared pathogenesis from the shared genetics of immune-related diseases

29 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Genomics and the multifactorial nature of human autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

The complex role of estrogens in inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Genetics of systemic lupus erythematosus and Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Genetic susceptibility to systemic lupus erythematosus in the genomic era

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Drugs and autoimmunity--a contemporary review and mechanistic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Prevention of autoimmune rheumatic disease: state of the art and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Recent advances in the immunogenetics of idiopathic inflammatory myopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Long-term outcome of mothers of children with isolated heart block in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

The innate immune system in SLE: type I interferons and dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Cancer immunotherapy via dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Type I interferon in systemic lupus erythematosus and other autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

HLA-DRhigh/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Long-lived autoreactive plasma cells drive persistent autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Interleukin-17 and type 17 helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

1 reference

7 January 2021

Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generati

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Th17 and natural Treg cell population dynamics in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Immature muscle precursors are a source of interferon-β in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Immunopathogenesis of Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Identification of regulatory T cells in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Quantification and molecular characterization of regulatory T cells in connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Follicular helper T cells in immunity and systemic autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Disturbance of cytokine networks in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Mechanisms of B cell autoimmunity in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

B-cell tolerance checkpoints in health and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Persistent expression of autoantibodies in SLE patients in remission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Immunoglobulin variable-region gene usage in systemic autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Identification and characterization of a human CD5+ pre-naive B cell population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

The role of IL-21 in regulating B-cell function in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

B cell maturation antigen deficiency exacerbates lymphoproliferation and autoimmunity in murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

New treatments for SLE: cell-depleting and anti-cytokine therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Tertiary lymphoid organs in infection and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Chronic inflammation caused by lymphotoxin is lymphoid neogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

The development of inducible bronchus-associated lymphoid tissue depends on IL-17.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren's syndrome in Scandinavian samples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

The dynamic structure of the germinal center.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Clearance deficiency and systemic lupus erythematosus (SLE).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960954-X

7 January 2021

10.1016/S0140-6736(13)60954-X

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23993191